We have no "intervention" data for this trial. Help us by contributing data.
The aim of the study is to evaluate whether peripheral circulating cell-free tumor DNA(ctDNA) can help early screening of pancreatic cancer recurrence or not. And we are also planning to evaluate correlation between ctDNA with clinical outcome of pancreatic cancer.
We have no "publications" for this trial. Help us by contributing data.